DCR is requesting the services of leidos biomedical research, INC. To initiate management, oversight, execution, closeout and publication of findings of a prospective observational study of adult…
Active Awarded Last action
- Contract number
- 75N91020F00025
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $89,188,376
Award facts
- Contract value 67% obligated
-
- $89,188,376.00 Current, with exercised options
- $134,064,345.00 Potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $2,140,115 | |
| Terminate for Convenience | -$7,711,041 | |
| Exercise an Option | $34,474,770 | |
| Other Administrative Action | $13,088,319 | |
| Exercise an Option | $17,237,385 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,711,041 | |
| Exercise an Option | $9,824,009 | |
| Exercise an Option | $8,758,455 | |
| Original award | $3,665,323 |
Show all 13
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Leidos Biomedical Research Inc. The $134,064,345 cost-plus-fixed-fee contract is for Leidos Biomedical Research to manage, oversee, execute, and publish findings of a prospective observational study on adult and pediatric patients with unknown febrile illness. The contract does not have a set-aside designation.
As a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute, Leidos Biomedical Research provides a range of biomedical research and facilities support services to federal agencies, with a focus on supporting programs at the National Institutes of Health. The company has extensive experience in areas such as clinical trials management, manufacturing of therapeutics and vaccines, and specialized laboratory testing. Leidos Biomedical Research will be collaborating with subcontractor Mitchell Group Inc., a minority-owned, veteran-owned small business, to provide operational support, management, and logistics for the clinical research activities.
Description
DCR is requesting the services of leidos biomedical research, INC. To initiate management, oversight, execution, closeout and publication of findings of a prospective observational study of adult and pediatric patients with unknown febrile illness FR
Quick answers
Who was awarded contract 75N91020F00025?
75N91020F00025 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2020.
How much is contract 75N91020F00025 worth?
The government has obligated $89,188,376 on 75N91020F00025. Its potential value, with all options, is $134,064,345.
Which agency awarded contract 75N91020F00025?
National Cancer Institute (National Institutes of Health) awarded 75N91020F00025, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91020F00025 an order under another contract?
Yes. 75N91020F00025 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00025 competed?
The extent of competition for 75N91020F00025 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award